Genesee Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Genesee Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$553K	Hold	16,314	–	–	0.17%	98
2026 Q1	$491K	Sell	16,314 -50	-0.3%	-$1.61K	0.21%	84
2025 Q4	$511K	Hold	16,364	–	–	0.21%	81
2025 Q3	$331K	Buy	16,364 +3,000	+22%	+$52.7K	0.14%	91
2025 Q2	$224K	Hold	13,364	–	–	0.1%	109
2025 Q1	$205K	Sell	13,364 -1,664	-11%	-$29.7K	0.1%	111
2024 Q4	$331K	Buy	15,028 +1,664	+12%	+$30.3K	0.15%	98
2024 Q3	$241K	Hold	13,364	–	–	0.12%	110
2024 Q2	$217K	Hold	13,364	–	–	0.11%	110
2024 Q1	$189K	Hold	13,364	–	–	0.1%	115
2023 Q4	$140K	Hold	13,364	–	–	0.09%	108
2023 Q3	$136K	Hold	13,364	–	–	0.1%	89
2023 Q2	$101K	Hold	13,364	–	–	0.07%	86
2023 Q1	$118K	Hold	13,364	–	–	0.08%	83
2022 Q4	$122K	Hold	13,364	–	–	0.09%	75
2022 Q3	$108K	Hold	13,364	–	–	0.08%	80
2022 Q2	$100K	Hold	13,364	–	–	0.07%	89
2022 Q1	$125K	Hold	13,364	–	–	0.07%	104
2021 Q4	$107K	Buy	13,364 +1,975	+17%	+$17.8K	0.05%	105
2021 Q3	$111K	Buy	+11,389	New	+$107K	0.05%	108
2021 Q2	–	Sell	-11,389	Closed	-$131K	–	116
2021 Q1	$131K	Hold	11,389	–	–	0.08%	87
2020 Q4	$109K	Hold	11,389	–	–	0.07%	81
2020 Q3	$102K	Hold	11,389	–	–	0.08%	71
2020 Q2	$140K	Hold	11,389	–	–	0.13%	68
2020 Q1	$102K	Buy	+11,389	New	+$117K	0.1%	73

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Genesee Capital Advisors's TEVA Position: Q2 2026 in Review

Genesee Capital Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 16,314 shares worth $553K. The position accounts for 0.17% of the portfolio, ranked #98.

Genesee Capital Advisors first reported a position in TEVA in Q1 2020 and has held it in 25 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Genesee Capital Advisors held 16,314 shares of Teva Pharmaceuticals worth $553K as of Q2 2026.
Genesee Capital Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.17% of Genesee Capital Advisors's portfolio in Q2 2026, its #98 holding.
Genesee Capital Advisors first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.